Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Will Activist Nelson Peltz’s Latest Win Against DuPont Change Hedge Fund Sentiment Towards the Stock?

Nelson Peltz of Trian Partners may have just won another battle in its ongoing war with E I Du Pont De Nemours And Co (NYSE:DD). After the markets closed on Monday, DuPont announced that Ellen Kullman will be stepping down as chairwoman and Chief Executive Officer on October 16. Kullman battled Peltz all the way to a shareholder vote in spring as the activist investor was seeking multiple board seats and a breakup of DuPont. Surprisingly, our data show that the hedge fund industry was not bullish on DuPont as Peltz was struggling to push for changes meant to increase shareholder value.

Chemistry Research 2

Following activist funds like Trian Partners is important because it is a very specific and focused strategy in which the investor doesn’t have to wait for catalysts to realize gains in the holding. A fund like Trian can simply create its own catalysts by pushing for them through negotiations with the company’s management and directors. In recent years, the average returns of activist hedge funds have been much higher than the returns of their passive peers. Furthermore, we have found through extensive research that the top small-cap picks of hedge funds are also capable of generating high returns and built a system around this premise. In the 32 months since our small-cap strategy was launched it has returned 118% and beaten the S&P500 ETF (SPY) by more than 60 percentage points (read more details). Soon, we’ll be releasing a new quarterly newsletter written by former activist hedge fund analyst Michael Bland that tracks 10 or so activist campaigns at any given time.

Nelson Peltz
Nelson Peltz
Trian Partners

According to E I Du Pont De Nemours And Co (NYSE:DD), Kullman, who is now 59 years old and has led the company for seven years, will be leaving the company on October 16 with board member Edward Breen replacing her as interim CEO. Shares of DuPont reached $54.42 in after-market trading after the announcement before settling at $54.29 per share or 5.87% above its closing price on Monday. Year-to-date, the stock has declined by over 31% and over the last 12 months, the slump is at more than 27%.

Follow Dupont E I De Nemours & Co (NYSE:CTAPRA,B)
Trade (NYSE:CTAPRA,B) Now!

It should be noted, however, that Fortune reported Kullman was not forced into stepping down. Citing an unnamed source, the publication said that the top executive’s decision to leave was her own. It added, however, that when Kullman approached the DuPont board about retiring, there was a “mutual agreement that […] it was time for Kullman and DuPont to part ways.” There was no ultimatum from Nelson Peltz, the source said, though Kullman’s battle with the activist investor “clearly left her bruised.” Kullman is one of the few executives to have fought activist investors, who have had more success in getting concessions from companies than in publicly fighting them. Peltz, meanwhile, may have said that he does not want another proxy battle with DuPont, but he does not like losing money either, pointing to continued pressure on the company to act on his proposals.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.